The COVID-19 pandemic has had a negative impact on the European enterprise solution market. However, following a period of recovery, the market will grow strongly through 2032, driven by the increasing movement toward improving market conditions, growing cybersecurity concerns, emerging legislative support, and the obsolescence of legacy healthcare IT infrastructure.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for enterprise solutions in Europe from 2019 through 2032.
The COVID-19 pandemic had negatively impacted the Europe enterprise solution market.
How strongly has the enterprise solution market been impacted?
At what pace is the enterprise solution market recovering?
Although VNA technology in Europe is highly regarded as a future keystone in healthcare IT structure, enterprise PACS will continue to represent a large portion of the overall market.
What are the key differences between VNA and enterprise PACS, and how do these differences contribute to the value proposition of each technology?
How will the VNA and enterprise PACS segments grow going forward? Which segment will be more dominant in the overall enterprise solutions market?
What factors contribute to growth of the VNA and enterprise PACS segments?
Vendors of enterprise solutions must develop new competitive strategies to address the evolving purchasing priorities and needs of healthcare facilities.
How will mergers and acquisitions change the competitive landscape of enterprise solutions?
How will value-based healthcare and declining physician influence affect purchasing decisions for enterprise solution technologies?
How must traditional PACS vendors position themselves in a market that increasingly prioritizes vendor neutrality and interoperability between HCIT solutions?
How will AI integration affect the competitiveness of certain companies?
What tactics can dedicated image exchange solution vendors use to stay relevant in a market with rapidly changing preferences?
Government incentives for the adoption of digital health solutions, including EHR, will promote the adoption of enterprise solutions in the European market.
What are the key differences between the European and US markets for enterprise solutions?
How will emerging government incentive programs shift purchasing priorities between VNA, enterprise PACS, and dedicated image exchange solutions?
How will the direction of future government legislation affect the competitive dynamics within the market?